Amit Sachdev - 10 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2023
Transactions value $
-$2,157,492
Form type
4
Filing time
14 Feb 2023, 16:06:18 UTC
Previous filing
03 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$768K -2.61K -3.27% $294.33 77.1K 10 Feb 2023 Direct
transaction VRTX Common Stock Tax liability -$1.39M -4.66K -6.04% $298.26 72.5K 13 Feb 2023 Direct
holding VRTX Common Stock 882 10 Feb 2023 401(k)
holding VRTX Common Stock 8.86K 10 Feb 2023 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.